Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by FireBeyond on Tuesday March 07, 2017 @12:50PM
(#13812725)
When a quarter of their revenue goes on sales and marketing that is pretty subjectively "unnecessary" I don't they can claim with a straight face that it's "subsidizing the world". Especially when they're already making $14B a year in profit, in J&J's case.
[ Parent
| on HN ]
Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by cmdrfred on Tuesday March 07, 2017 @12:56PM
(#13812789)
Also if the risk is so high why are drug companies so profitable over the long term? Pharma firms are head and shoulders the most profitable firms in the S&P 500 every single year.
Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by akiselev on Tuesday March 07, 2017 @01:28PM
(#13813129)
High risk, high reward. Why would anyone take a higher risk for a lower reward?
Pharmaceutical companies in the S&P500 are so profitable because of barriers to entry, massive capital requirements, and a whole biotechnology industry feeding them acquisitions. Biotech startups going under with zero revenue after raising hundreds of millions of dollars from VCs and institutional investors is a regular occurrence. Since the brunt of the pure research is publicly funded and other investors chasing ROI take care of much of the R&D risk, big pharma companies benefit a lot from other people's money just for providing exit opportunities for smaller companies.